Login / Signup

Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD.

Maurizio BenucciArianna DamianiGianfranco GiannasiFrancesca Li GobbiLuca QuartuccioValentina GrossiMaria InfantinoMariangela Manfredi
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • risk factors
  • oxidative stress
  • respiratory syndrome coronavirus
  • newly diagnosed